Washington Gov. Jay Inslee made a significant move April 27 by signing a groundbreaking health privacy law. The My Health My Data Act introduces an all-encompassing privacy framework for organizations operating in the state that deal with consumer health data not protected by HIPAA.
Washington is the only state that has enacted a law specifically targeting privacy and security of medical and health-related information not covered by HIPAA. But lawmakers in other states have also noted the gap in protections for this kind of information, and have proposed or are considering similar laws.
Among other things, Washington’s law, effective March 31, 2024, requires the following of each regulated entity—those conducting business in Washington, or producing or providing products or services targeting consumers in Washington:
The MHMDA also prohibits regulated entities from implementing a geofence around facilities that provide in-person health-care services, if the geofence is used to identify or track consumers seeking health care services, collect health data from consumers, or send unsolicited messages to persons at such health facilities. Significantly, the MHMDA also includes strict biometric privacy rules and provides a robust private right of action for consumers to sue companies for any violations of the MHMDA.
Here is the latest on those states that may follow Washington’s lead.
New York. On Jan. 4, the New York Health Information Privacy Act was introduced in the Senate. The bill broadly defines health information as any information relating to an individual, or a device that is reasonably linkable to an individual, in connection with physical or mental health, and includes location or payment information relating to an individual’s physical or mental health and any data derived from it.
If passed, the law would require regulated entities—defined broadly as any entity that controls the processing of health information of individuals in New York—to, among other things:
Unlike the MHMDA, there are no provision requiring businesses to delete data from archived or backup systems. Like the MHMDA, the bill includes data sale prohibitions and a private right of action. However, it lacks that law’s specific biometric consent requirements.
Maine. On May 9, Maine’s legislature introduced the Act to Protect Personal Health Data to the Maine House of Representatives, modeled on the MHMDA.
Massachusetts. Massachusetts lawmakers filed companion bills HD 3855 and SD 2118 for a Consumer Health Data Act, modeled on the MHMDA, but without that law’s geofencing prohibitions.
Nevada. SB 370 was introduced in the Senate on March 23, including provisions that largely mirror the MHMDA, but not providing for a private right of action.
Illinois. On Feb. 9, the Health Data Privacy Act was introduced in the Illinois Senate. The bill currently lacks text.
While the MHMDA and these other state bills would focus specifically on health-related information, current state consumer privacy laws also include enhanced obligations for processing of sensitive personal information, including health information. For example, privacy laws in Virginia, Colorado, and Connecticut require companies obtain consumer opt-in consent and conduct data protection impact assessments prior to processing sensitive data, including health information.
In comparison, the California Consumer Privacy Act, as amended by the California Privacy Rights Act, adopts a less stringent standard by giving consumers the right to limit the use of their sensitive personal information. Similarly, under the Utah Consumer Privacy Act, controllers may process sensitive data on an opt-out rather than opt-in basis.
Businesses that collect consumer health information should closely monitor the trajectory of state health data privacy bills and prepare to strengthen protections for this data. Given the broad scope of the MHMDA and its stringent requirements, businesses subject to it could leverage efforts to ensure compliance with similar health data laws that may be passed in other states in the near future.
This article does not necessarily reflect the opinion of Bloomberg Industry Group, Inc., the publisher of Bloomberg Law and Bloomberg Tax, or its owners.
Jacqueline Klosek is partner at Goodwin’s technology/life sciences group, concentrating on data, privacy, and cybersecurity, intellectual property transactions, health care, hospitality, and tech M&A practices.
Federica De Santis is an associate at Goodwin’s technology group and data, privacy, and cybersecurity practice.
Write for Us: Author Guidelines
David Van Bruwaene was pursuing his Ph.D. in philosophy at Cornell when he developed a passion for linguistics and natural language processing, the subfiel
New nature-reporting recommendations aim to help companies assess their impact on and risks from the world’s natural systems. It could become mandatory one da
To the Editor:The article “Welcome to the ‘Walled Garden.’ Is This Education’s Solution to AI’s Pitfalls?” (July 25, 2023) raises important quest
A year and a half after Ukraine was invaded by Russia, 84% of the nation’s companies are fully operational, according to a survey by t